126 related articles for article (PubMed ID: 10813278)
1. Serum C-reactive protein does not predict rheumatoid arthritis.
Aho K; Palosuo T; Knekt P; Alha P; Aromaa A; Heliövaara M
J Rheumatol; 2000 May; 27(5):1136-8. PubMed ID: 10813278
[TBL] [Abstract][Full Text] [Related]
2. Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion.
Aho K; Palosuo T; Heliövaara M; Knekt P; Alha P; von Essen R
J Rheumatol; 2000 Dec; 27(12):2743-6. PubMed ID: 11128658
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.
Nielen MM; van Schaardenburg D; Reesink HW; Twisk JW; van de Stadt RJ; van der Horst-Bruinsma IE; de Gast T; Habibuw MR; Vandenbroucke JP; Dijkmans BA
Arthritis Rheum; 2004 Aug; 50(8):2423-7. PubMed ID: 15334453
[TBL] [Abstract][Full Text] [Related]
4. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein in the prediction of rheumatoid arthritis in women.
Shadick NA; Cook NR; Karlson EW; Ridker PM; Maher NE; Manson JE; Buring JE; Lee IM
Arch Intern Med; 2006 Dec 11-25; 166(22):2490-4. PubMed ID: 17159015
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio.
Kokubun M; Imafuku Y; Okada M; Ohguchi Y; Ashikawa T; Yamada T; Yoshida H
Clin Chim Acta; 2005 Oct; 360(1-2):97-102. PubMed ID: 15932751
[TBL] [Abstract][Full Text] [Related]
8. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis.
Lopez-Olivo MA; Gonzalez-Lopez L; Garcia-Gonzalez A; Villa-Manzano AI; Cota-Sanchez AR; Salazar-Paramo M; Varon-Villalpando E; Cardona-Muñoz EG; Gamez-Nava JI
Scand J Rheumatol; 2006; 35(2):112-6. PubMed ID: 16641044
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
12. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
[TBL] [Abstract][Full Text] [Related]
13. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
Yoo WH
J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
[TBL] [Abstract][Full Text] [Related]
14. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.
Nyhäll-Wåhlin BM; Petersson IF; Nilsson JA; Jacobsson LT; Turesson C;
Rheumatology (Oxford); 2009 Apr; 48(4):416-20. PubMed ID: 19213849
[TBL] [Abstract][Full Text] [Related]
15. Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.
Choi HK; Seeger JD
J Rheumatol; 2005 Dec; 32(12):2311-6. PubMed ID: 16331755
[TBL] [Abstract][Full Text] [Related]
16. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
[TBL] [Abstract][Full Text] [Related]
17. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
18. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
[TBL] [Abstract][Full Text] [Related]
19. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis.
Ward MM
J Rheumatol; 2004 May; 31(5):884-95. PubMed ID: 15124246
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
Dessein PH; Joffe BI; Stanwix AE
J Rheumatol; 2004 Jun; 31(6):1095-7. PubMed ID: 15170920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
